GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RBC Bioscience Corp (ROCO:6848) » Definitions » Additional Paid-In Capital

RBC Bioscience (ROCO:6848) Additional Paid-In Capital : NT$50.5 Mil(As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is RBC Bioscience Additional Paid-In Capital?


RBC Bioscience's quarterly additional paid-in capital stayed the same from Dec. 2023 (NT$50.5 Mil) to Jun. 2024 (NT$50.5 Mil) and stayed the same from Jun. 2024 (NT$50.5 Mil) to Dec. 2024 (NT$50.5 Mil).

RBC Bioscience's annual additional paid-in capital stayed the same from Dec. 2022 (NT$50.5 Mil) to Dec. 2023 (NT$50.5 Mil) and stayed the same from Dec. 2023 (NT$50.5 Mil) to Dec. 2024 (NT$50.5 Mil).


RBC Bioscience Additional Paid-In Capital Historical Data

The historical data trend for RBC Bioscience's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RBC Bioscience Additional Paid-In Capital Chart

RBC Bioscience Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial - 50.45 50.45 50.45 50.45

RBC Bioscience Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.45 50.45 50.45 50.45 50.45

RBC Bioscience Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

RBC Bioscience Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of RBC Bioscience's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


RBC Bioscience Business Description

Traded in Other Exchanges
N/A
Address
No. 15, Qiaohe Road, 15th Floor, Zhonghe District, New Taipei City, TWN, 23145
RBC Bioscience Corp is a bio-sciences company. Its products include the manufacture and sale of molecular biological medical diagnosis and research reagents, gene extraction automatic testing instruments, and gene extraction reagent tissues.

RBC Bioscience Headlines

No Headlines